Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
The authors discuss the action mechanisms of β-adrenoblockers (β-AB), as well as pharmacokinetics, pharmacodynamics, and drug interaction of a highly selective β-AB bisoprolol. The paper presents the data on bisoprolol effectiveness and safety in arterial hypertension, coronary heart disease, chroni...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1837 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689395554156544 |
|---|---|
| author | O. D. Ostroumova E. A. Smolyarchuk |
| author_facet | O. D. Ostroumova E. A. Smolyarchuk |
| author_sort | O. D. Ostroumova |
| collection | DOAJ |
| description | The authors discuss the action mechanisms of β-adrenoblockers (β-AB), as well as pharmacokinetics, pharmacodynamics, and drug interaction of a highly selective β-AB bisoprolol. The paper presents the data on bisoprolol effectiveness and safety in arterial hypertension, coronary heart disease, chronic heart failure, and their combination with other diseases. |
| format | Article |
| id | doaj-art-eacbabb0f9d6419b8565452e57feb931 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2011-06-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-eacbabb0f9d6419b8565452e57feb9312025-08-20T03:21:39Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-06-01103768210.15829/1728-8800-2011-3-76-821552Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical featuresO. D. Ostroumova0E. A. Smolyarchuk1I.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityThe authors discuss the action mechanisms of β-adrenoblockers (β-AB), as well as pharmacokinetics, pharmacodynamics, and drug interaction of a highly selective β-AB bisoprolol. The paper presents the data on bisoprolol effectiveness and safety in arterial hypertension, coronary heart disease, chronic heart failure, and their combination with other diseases.https://cardiovascular.elpub.ru/jour/article/view/1837β-adrenoblockerbisoprololarterial hypertensioncoronary heart diseasechronic heart failure |
| spellingShingle | O. D. Ostroumova E. A. Smolyarchuk Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features Кардиоваскулярная терапия и профилактика β-adrenoblocker bisoprolol arterial hypertension coronary heart disease chronic heart failure |
| title | Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features |
| title_full | Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features |
| title_fullStr | Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features |
| title_full_unstemmed | Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features |
| title_short | Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features |
| title_sort | pharmacokinetics and pharmacodynamics of a β adrenoblocker bisoprolol from mechanisms of action to clinical features |
| topic | β-adrenoblocker bisoprolol arterial hypertension coronary heart disease chronic heart failure |
| url | https://cardiovascular.elpub.ru/jour/article/view/1837 |
| work_keys_str_mv | AT odostroumova pharmacokineticsandpharmacodynamicsofabadrenoblockerbisoprololfrommechanismsofactiontoclinicalfeatures AT easmolyarchuk pharmacokineticsandpharmacodynamicsofabadrenoblockerbisoprololfrommechanismsofactiontoclinicalfeatures |